Compare TSE & ICCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TSE | ICCC |
|---|---|---|
| Founded | 2010 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 68.0M | 55.5M |
| IPO Year | 2014 | 1987 |
| Metric | TSE | ICCC |
|---|---|---|
| Price | $0.56 | $6.06 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $1.00 | N/A |
| AVG Volume (30 Days) | ★ 671.3K | 22.4K |
| Earning Date | 11-06-2025 | 11-13-2025 |
| Dividend Yield | ★ 4.75% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.26 |
| Revenue | ★ $3,133,800,000.00 | $27,769,304.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $4.47 | N/A |
| P/E Ratio | ★ N/A | $24.05 |
| Revenue Growth | N/A | ★ 16.49 |
| 52 Week Low | $0.60 | $4.28 |
| 52 Week High | $6.85 | $7.60 |
| Indicator | TSE | ICCC |
|---|---|---|
| Relative Strength Index (RSI) | 26.08 | 60.10 |
| Support Level | $0.60 | $4.72 |
| Resistance Level | $0.76 | $5.36 |
| Average True Range (ATR) | 0.08 | 0.34 |
| MACD | 0.01 | 0.17 |
| Stochastic Oscillator | 0.60 | 88.46 |
Trinseo PLC is a materials company and manufacturer of latex and plastics products. The company's operating segments include Latex Binders, Americas Styrenics, Engineered Materials, and Polymer Solutions. Maximum revenue is generated from its Polymer Solutions segment, which consists of various polymers, the majority of which are for automotive, building, and construction applications. The product offerings of this segment include ABS, styrene-acrylonitrile, polystyrene, and polycarbonate products, which are marketed through brands like Magnum and Styron. Geographically, the company generates maximum revenue from Europe, followed by the United States, Asia-Pacific, and the Rest of the world.
ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.